SMOOTH UPPER LIP PROFESSIONAL Perioral Lip Anti-Aging Treatment by Dermelect Cosmeceuticals

What is Equest Gel Horse Wormer 12.2 Gm 1 Syringe?

Equest Gel Horse Wormer 12.2 Gm 1 Syringe is a veterinary-formulated deworming solution designed specifically for horses. Each syringe delivers a precise 12.2 gram dose of moxidectin at 2.2%, a potent active ingredient known for its efficacy against a wide range of internal parasites, including encysted small strongyles. This product supports long-term equine health by targeting both adult worms and dormant larval stages, helping prevent colic and weight loss linked to infestations. It's administered orally and designed for ease of use with an adjustable dosing ring calibrated to the horse's weight.

Key features

• Active Ingredient — Contains 2.2% moxidectin, effective against resistant and encysted parasites.
• Dose Precision — Syringe with weight-adjustable ring ensures accurate administration.
• Broad-Spectrum Control — Targets roundworms, bots, strongyles, and pinworms.
• Single-Dose Treatment — One syringe treats one horse, no mixing required.
• Prescription-Strength — Vet-recommended formulation for professional parasite management.
• Extended Withdrawal Interval — Up to 14 days, allowing time before slaughter or milk discard.
• Trusted Brand — Equest is widely used in equine care for consistent results.

Who is Equest Gel Horse Wormer 12.2 Gm 1 Syringe for?

This dewormer is ideal for horse owners, trainers, and equine veterinarians managing parasite loads in adult horses and weanlings over 6 months. It’s especially valuable during seasonal rotation programs or when combating known infestations of encysted larvae. Facilities with multiple horses benefit from its reliability and targeted dosing, reducing the risk of under- or overdosing. Not intended for ponies under 200 lbs or foals younger than 6 months.

How does Equest Gel Horse Wormer 12.2 Gm 1 Syringe compare?

Compared to standard fenbendazole or pyrantel-based dewormers, Equest Gel offers superior control of encysted small strongyles, which are often resistant to older drug classes. It lasts longer in the system, providing extended suppression of reinfestation. Unlike paste dewormers with shorter residual activity, Equest’s moxidectin base delivers deeper tissue penetration. It is more specialized than general over-the-counter options, making it better suited for strategic deworming rather than routine monthly use. When compared to combination products like Eqvalan Duo, it lacks praziquantel, so it does not target tapeworms—making it best used in rotation or alongside other treatments.